CD8A and neoplasm: Signaling through VEGFRs and FGFRs promotes tumor-associated angiogenesis (20, 21), and FGFR activation results in decreased Tregs, programmed death ligand-1 (PD-L1) expression, and increased IFN-γ+CD8+ T cells (22, 23).